JL
Therapeutic Areas
Laboratorio Reig Jofre Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Vincobiosis® Acneic | Acne | Approved/Commercial |
| RegeNail® | Onychomycosis (Nail fungus) | Approved/Commercial |
| DexULac® | Dermatological condition | Approved/Commercial |
| TRIFERTY-ATM® | Not Specified | Approved/Commercial |
| Leanbio Integration | Biotech CDMO Platform | Platform |
| Syna Therapeutics | Vertical Integration Project | Platform |
| European Vaccine Capacity | Pandemic Preparedness | Manufacturing |
| Forte Pharma E-commerce | Wellness Products | Commercial |
Leadership Team at Laboratorio Reig Jofre
IB
Ignasi Biosca Reig
Chairman of the Board of Directors
JL
Juan López-Belmonte Encina
Lead Independent Director, Chairman of the Appointments and Remuneration Committee
LB
Luis Bago Martínez
Independent Director, Chairman of the Audit and Control Committee
MB
Marta Bajo Fernández
Independent Director
ML
María Luisa Poncela García
Independent Director
ÁL
Álvaro Lenze
Analyst at Alantra Equities
ÁB
Álvaro Bernal
Analyst at Alantra Equities
PE
Pedro Echeguren
Analyst at Bankinter Securities
FR
Francisco Ruiz
Analyst at BNP Paribas Exane
MM
María Mira
Analyst at Estrategias de inversión